Studies have identified that CXCR4, a G protein-coupled receptor, is involved in tumorigenesis by promoting M2 polarization owing to its higher expression in HCC due to sorafenib treatment [122]. This evidence concerns the gene CXCR4 and hepatocellular carcinoma.